Feasibility of a standard cognitive assessment in European academic memory clinics.

INTRODUCTION Standardized cognitive assessment would enhance diagnostic reliability across memory clinics. An expert consensus adapted the Uniform Dataset (UDS)-3 for European centers, the clinician's UDS (cUDS). This study assessed its implementation acceptability and feasibility. METHODS We developed a survey investigating barriers, facilitators, and willingness to implement the cUDS. With a mixed-methods design, we analyzed data from academic memory clinics. RESULTS Seventy-eight percent of responding clinicians were experienced neuropsychologists/psychologists and 22% were medical specialists coming from 18 European countries. Sixty-five percent clinicians were willing to implement cUDS. General barriers related to implementation (43%) and clinical-methodological domains (21%). Favorable clinicians reported finances (15%) and digitalization (9%) as facilitating, but unavailability of local norms (23%) as hindering. Unfavorable clinicians reported logistical (23%) and time issues (18%). DISCUSSION Despite challenges, data showed moderate clinicians' acceptability and requirements to improve feasibility. Nonetheless, these results come from academic clinicians. The next steps will require feasibility evaluation in non-academic contexts.

[1]  A. O’Cathain,et al.  Adapting interventions to new contexts—the ADAPT guidance , 2021, BMJ.

[2]  Kwun Chuen Gary Chan,et al.  Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[3]  B. Dubois,et al.  Biomarker counseling, disclosure of diagnosis and follow‐up in patients with mild cognitive impairment: A European Alzheimer's disease consortium survey , 2020, International journal of geriatric psychiatry.

[4]  H. Hampel,et al.  Biomarkers for Alzheimer’s Disease (AD) and the Application of Precision Medicine , 2020, Journal of personalized medicine.

[5]  F. Molnar,et al.  One Size Does Not Fit All: Choosing Practical Cognitive Screening Tools for Your Practice , 2020, Journal of the American Geriatrics Society.

[6]  Rachel C. Shelton,et al.  Advancing health equity through CTSA programs: Opportunities for interaction between health equity, dissemination and implementation, and translational science , 2020, Journal of Clinical and Translational Science.

[7]  Kwun Chuen Gary Chan,et al.  Differentiating among stages of cognitive impairment in aging: Version 3 of the Uniform Data Set (UDS) neuropsychological test battery and MoCA index scores , 2020, Alzheimer's & dementia.

[8]  B. Dubois,et al.  Rationale for Early Diagnosis of Mild Cognitive Impairment (MCI) supported by Emerging Digital Technologies , 2019, The Journal of Prevention of Alzheimer's Disease.

[9]  Kai Wang,et al.  Consensus statement on the neurocognitive outcomes for early detection of mild cognitive impairment and Alzheimer dementia from the Chinese Neuropsychological Normative (CN-NORM) Project , 2019, Journal of global health.

[10]  R. Harwood,et al.  PROTOCOL FOR THE PROCESS EVALUATION OF THE PROMOTING ACTIVITY, INDEPENDENCE AND STABILITY IN EARLY DEMENTIA AND MILD COGNITIVE IMPAIRMENT (PRAISED 2) RANDOMISED CONTROLLED TRIAL , 2019, Alzheimer's & Dementia.

[11]  S. Teipel,et al.  A Tablet App– and Sensor-Based Assistive Technology Intervention for Informal Caregivers to Manage the Challenging Behavior of People With Dementia (the insideDEM Study): Protocol for a Feasibility Study , 2018, JMIR research protocols.

[12]  G. Mountain,et al.  Alzheimer Europe's position on involving people with dementia in research through PPI (patient and public involvement) , 2018, Aging & mental health.

[13]  V. Mor,et al.  Identifying and Supporting Nonpharmacological Dementia Interventions Ready for Pragmatic Trials: Results From an Expert Workshop. , 2018, Journal of the American Medical Directors Association.

[14]  J. Clarimón,et al.  Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.

[15]  Fernán Gonzalez Bernaldo de Quirós,et al.  Change Management Strategies: Transforming a Difficult Implementation into a Successful One , 2017, MedInfo.

[16]  T. Kan,et al.  Use and implementation of standard operating procedures and checklists in prehospital emergency medicine: a literature review. , 2016, The American journal of emergency medicine.

[17]  A. Fagan,et al.  Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research , 2015, Alzheimer's & Dementia.

[18]  A. O’Cathain,et al.  Process evaluation of complex interventions: Medical Research Council guidance , 2015, BMJ : British Medical Journal.

[19]  David R. Roalf,et al.  Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging , 2013, Alzheimer's & Dementia.

[20]  J. Becker,et al.  Normative data of a brief neuropsychological battery for Spanish individuals older than 49 , 2012, Journal of clinical and experimental neuropsychology.

[21]  A. Monsch,et al.  Comparison of verbal episodic memory measures: Consortium to establish a registry for Alzheimer's disease - neuropsychological assessment battery (CERAD-NAB) vs. California verbal learning test (CVLT) , 2011, Alzheimer's & Dementia.

[22]  Ruth E Nieuwenhuis-Mark,et al.  The Death Knoll for the MMSE: Has It Outlived Its Purpose? , 2010, Journal of geriatric psychiatry and neurology.

[23]  J. Mackenbach,et al.  Class-related health inequalities are not larger in the East: a comparison of four European regions using the new European socioeconomic classification , 2008, Journal of Epidemiology & Community Health.

[24]  B. Vellas,et al.  The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey , 2005, International journal of geriatric psychiatry.

[25]  A. Monsch,et al.  Normal ranges of neuropsychological tests for the diagnosis of Alzheimer's disease. , 2000, Studies in health technology and informatics.

[26]  R. Nickerson Confirmation Bias: A Ubiquitous Phenomenon in Many Guises , 1998 .